drugset / Trial / NCT04941703
"CHANGE COVID-19 Severity"
RandomizedParallel-groupTriple-blindTreatment
Summary
We are conducting an investigator-initiated, single center, blinded, placebo-controlled, randomized clinical trial evaluating magnesium citrate combined with a probiotic for the treatment of adults hospitalized with COVID-19.
Timeline
- Start
- 2021-11-04
- Primary completion
- 2022-06-25
- Completion
- 2022-06-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Magnesium Citrate | Unknown | 296 ml | Oral |